恒通股份: 恒通物流股份有限公司关于全资子公司收购股权的公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
股票代码:603223 股票简称:恒通股份 公告编号:2025-024 一、交易概述 公司已于2024年10月29日在上海证券交易所网站(www.sse.com.cn)披露了 《恒通物流股份有限公司关于注销控股子公司的公告》,因华恒能源需要注销, 其全资子公司广西华恒通股权需要进行处置,基于公司整体发展规划,为进一步 整合资源,更好地开展LNG相关业务,恒福绿洲拟收购标的资产。恒福绿洲拟与 华恒能源签署《股权转让合同》,约定以81,811,985.71元收购华恒能源持有的 广西华恒通100%股权。 本次交易资金来源为恒福绿洲的自有或自筹资金,收购价格系在对广西华恒 通所作尽职调查及在充分考虑其未来发展前景的基础上,结合评估结果,经交易 双方充分协商后确定。 公司于2025年7月1日召开第五届董事会第十一次会议,审议通过了《关于全 资子公司收购股权的议案》,根据《上海证券交易股票上市规则》及公司章程等 有关规定,本次交易事项在公司董事会审批权限范围内,无需提交公司股东大会 审议。 交易事项经公司第五届董事会第十一次会议审议通过后,与华恒能源签署《股权 转让合同》。 恒通物流股份有限公司 关于全资子公司收购股权的 ...
冠豪高新: 冠豪高新关于与诚通财务有限责任公司续签金融服务协议暨关联交易公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
Core Viewpoint - The company intends to renew the Financial Service Agreement with Chengtong Finance Co., Ltd. for another three years, which includes deposit, settlement, credit, and other financial services [1][2][7] Summary by Sections Transaction Overview - The renewal of the Financial Service Agreement is based on principles of equality, voluntariness, and good faith, with no significant risks involved [1][2] - The transaction is classified as a related party transaction and has been approved by the independent directors and the board of directors, pending approval from the shareholders' meeting [1][2] Related Party Information - Chengtong Finance Co., Ltd. is controlled by China Chengtong Holdings Group, with the company holding a 10% stake in Chengtong Finance [2][3] - As of December 31, 2024, Chengtong Finance has total assets of 33.448 billion yuan, total equity of 6.747 billion yuan, and a net profit of 1.79 billion yuan for the year [3] Financial Service Agreement Details - Chengtong Finance will provide services including deposits, settlements, credit services, and other approved financial services [4][6] - The total credit limit for loans and interest is capped at 2 billion yuan, subject to adjustment based on the company's operational needs [4] - The pricing for services will align with the prevailing rates set by the People's Bank of China and major commercial banks [4] Purpose and Impact of Related Transactions - The agreement aims to enhance the company's capital utilization and improve funding efficiency, while also broadening financing channels and reducing costs and risks [7] - The transaction is not expected to harm the interests of the company or minority shareholders [7] Approval Process - The agreement has been reviewed and approved by the independent directors and will be submitted for approval at the shareholders' meeting, where related shareholders will abstain from voting [7]
梅花生物: 梅花生物关于跨境收购业务与资产的进展公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
Group 1 - The company has signed a share and asset purchase agreement with Kirin Holdings' subsidiary to acquire certain businesses for 10.5 billion JPY (approximately 500 million CNY) [1] - The acquisition includes food amino acids, pharmaceutical amino acids, and human milk oligosaccharides (HMO) [1] - The final transaction price is approximately 16.8 billion JPY (about 833 million CNY) after adjustments based on cash reserves and working capital [2] Group 2 - The business transfer was completed on July 1, 2025, with all conditions of the agreement met [2] - As of June 30, 2025, the estimated cash on hand for the acquired assets was approximately 11.3 billion JPY (about 560 million CNY) [2] - The company will continue to monitor the progress of the acquisition and provide timely updates as required [2]
中恒集团: 广西梧州中恒集团股份有限公司关于政府收储控股孙公司土地的进展公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
证券代码:600252 证券简称:中恒集团 公告编号:临 2025-62 广西梧州中恒集团股份有限公司 关于政府收储控股孙公司土地的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: (以下简称"公司"或"中恒集团") 控股孙公司肇庆中恒制药有限公司(以下简称"肇庆中恒制药")收到肇庆高新 技术产业开发区土地储备中心(以下简称"肇庆高新区土储中心" )支付的欠付款 本金及利息 6,274,625.00 元。 一、土地收储概述 高新区土储中心提出的延期支付事项(即延期至 2025 年 12 月 31 日前清偿全部 债务),并同意控股孙公司就肇庆高新区土储中心拖欠的补偿款本金、利息及违 约金、土地抵押合同等事项签订相关补充协议。 签订上述补充协议后,公司控股孙公司肇庆中恒制药合计收到肇庆高新区土 储中心支付的欠付款本金及利息 53,324,788.20 元(含本次)。 具体内容详见公司于 2024 年 1 月 3 日、2024 年 1 月 30 日、2024 年 7 月 2 日、2024 年 10 月 9 日 ...
羚锐制药: 羚锐制药关于获得药品注册证书的公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
证券代码:600285 证券简称:羚锐制药 公告编号:2025-028 号 河南羚锐制药股份有限公司 关于获得药品注册证书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 近日,河南羚锐制药股份有限公司(以下简称"公司")子公司银谷制药有 限责任公司(以下简称"银谷制药")收到国家药品监督管理局核准签发的《药 品注册证书》,批准银谷制药自主研发的 1 类创新药苯环喹溴铵鼻喷雾剂新增适 应症,用于改善感冒引起的流涕、鼻塞、鼻痒和喷嚏症状。现将相关情况公告如 下: 一、 药品的基本情况 药品名称:苯环喹溴铵鼻喷雾剂 剂型:喷雾剂 规格:5ml:5mg,每瓶 50 喷,每喷含苯环喹溴铵 90μg;10ml:10mg,每瓶 100 喷,每喷含苯环喹溴铵 90μg 注册分类:化学药品 2.4 类 证书编号:2025S01880、2025S01881 处方药/非处方药:处方药 审批结论:据《中华人民共和国药品管理法》及有关规定,经审查,本品符 合药品注册的有关要求,批准增加适应症,新增适应症为:"本品适用于改善感 冒引起的流涕、鼻塞 ...
北京科锐: 关于为子公司提供担保的公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
范运作》《公司章程》和《对外担保管理制度》的相关规定,本次担保事项无需 提交公司股东大会审议。 二、具体担保额度预计情况 | | | | | | | | | | | | | | | 单位:万元 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 被担保方最 | 截至公告 | 本次新 | | 本次新增担保额度占 | | 是否 | | | | | | | 担保 | | 担保方持股比 | | | | | | | | | | | | | | | 被担保方 | 近一期资产 | | | | 增担保 | 上市公司最近一期经 | 披露日担 | | 关 | | | | | | 联 | | | | | | | | | | | | | | | | 方 | | 例 | | | | | | | | | | | | | | | | 负债率 | | 保余额 | 额度 | | 审计净资产比例 | | | | 担保 | | | | | | 郑州科锐 | | | | | | | | | | | ...
冠豪高新: 冠豪高新关于诚通财务有限责任公司发生金融业务风险处置预案
Zheng Quan Zhi Xing· 2025-07-01 16:31
广东冠豪高新技术股份有限公司 关于诚通财务有限责任公司发生金融业务风险处置预案 第一章 总则 第一条 为有效防范、及时控制和化解广东冠豪高新技术股份有限公 司(以下简称"公司")及下属子公司在中国诚通控股集团有限公司(以 下简称"中国诚通")控股的诚通财务有限责任公司(以下简称"诚通 财务")金融业务的风险,保证资金安全,根据《上海证券交易所上市 公司自律监管指引第 5 号——交易与关联交易》的规定,特制定本风险 处置预案。 第二章 风险处置机构及职责 第二条 公司成立风险预防处置领导小组(以下简称"领导小组"), 由公司董事长任组长,为风险预防处置第一责任人,由公司总经理及分 管财务领导兼任副组长,领导小组成员包括资金业务部、会计信息部、 风险合规部等相关部门负责人。 领导小组负责组织开展金融业务风险的防范和处置工作,领导小组 在资金业务部下设工作组,由资金业务部协调配合工作组具体负责财务 公司日常监督与管理工作,并及时向领导小组反映情况,以便领导小组 按本预案防范和处置风险。 第三条 风险处置机构职责 (一)领导小组统一领导金融业务风险的应急处置工作,全面负责 在诚通财务金融业务风险的防范和处置工作。 ( ...
佳禾食品: 佳禾食品工业股份有限公司关于使用部分暂时闲置募集资金进行现金管理到期赎回的公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
证券代码:605300 证券简称:佳禾食品 公告编号:2025-057 佳禾食品工业股份有限公司 银行 构性存款 4/2 7/1 2.50% 7/1 关于使用部分暂时闲置募集资金进行现金管理 到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 佳禾食品工业股份有限公司(以下简称"公司")于 2025 年 3 月 14 日召开 第三届董事会第三次会议、第三届监事会第二次会议,于 2025 年 3 月 31 日召开 管理的议案》,同意公司及子公司使用闲置募集资金不超过人民币 5.5 亿元进行 现金管理,投资品种为安全性高、流动性好的低风险理财产品。该事项自股东大 会审议通过之日起 12 个月内有效,在前述资金额度及投资期限内,资金可以滚 动使用。公司监事会发表了明确的同意意见,保荐人中信证券股份有限公司出具 了明确的核查意见,具体内容详见公司于 2025 年 3 月 15 日在上海证券交易所网 站(www.sse.com.cn)披露的《关于使用部分闲置募集资金进行现金管理的公告》 (公告编号:2025-014)。 公司 ...
海峡环保: 海峡环保关于使用自有资金进行现金管理的进展公告
Zheng Quan Zhi Xing· 2025-07-01 16:31
股票代码:603817 股票简称:海峡环保 公告编号:2025-040 福建海峡环保集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示: ? 本次现金管理种类:国债逆回购、银行通知存款以及大额存单。 ? 本次现金管理额度:不超过人民币 3 亿元的闲置自有资金。 ? 履行的审议程序:2025 年 1 月 17 日,福建海峡环保集团股份 有限公司(以下简称"公司")召开第四届董事会第十二次会议,审 议通过了《关于使用自有资金进行现金管理的议案》。根据《公司章 程》等有关规定,本次现金管理事项无需提交公司股东大会审议。 ? 特别风险提示:公司及子公司将选择由具有合法经营资格的商 业银行、证券公司等金融机构发行的安全性高、流动性好的低风险投 资产品,但仍不排除因市场波动、宏观金融政策变化等原因引起的影 响收益的情况。敬请广大投资者注意投资风险。 一、本次现金管理概述 (一)现金管理目的 为提高公司资金使用效率,实现闲置自有资金的保值增值,在确 保不影响公司日常经营及资金安全并有效控制风险的前提下,增加公 ...
恒通股份: 广西华恒通能源科技有限公司审计报告
Zheng Quan Zhi Xing· 2025-07-01 16:31
Audit Opinion - The audit report states that the financial statements of Guangxi Huahengtong Energy Technology Co., Ltd. (hereinafter referred to as Huahengtong) have been prepared in accordance with accounting standards and fairly reflect the company's financial position as of February 28, 2025, and its operating results and cash flows for January to February 2025 [2][3]. Management and Governance Responsibilities - The management of Huahengtong is responsible for preparing financial statements that fairly reflect the company's financial position and for maintaining necessary internal controls to prevent material misstatements due to fraud or error [3][4]. - The governance layer is responsible for overseeing the financial reporting process of Huahengtong [3]. Auditor's Responsibilities - The auditor's goal is to obtain reasonable assurance that the financial statements are free from material misstatement, whether due to fraud or error, and to issue an audit report that includes the audit opinion [4][5]. - The auditor identifies and assesses risks of material misstatement due to fraud or error and designs audit procedures to address these risks [5][6]. Company Overview - Guangxi Huahengtong Energy Technology Co., Ltd. was established on September 22, 2017, with a registered capital of RMB 100 million. The company is located at 31 Chating Road, Beihai City [6][7]. - The company's business scope includes new energy technology consulting, machinery equipment leasing, road cargo transportation, and sales of gas appliances and related components [6]. Financial Reporting Basis - The financial statements are prepared on a going concern basis, reflecting that the company has stable operations and a reasonable asset-liability structure, with no significant adverse risks affecting its ability to continue as a going concern [7][8]. Important Accounting Policies - The company follows the accrual basis of accounting and measures assets at historical cost, with provisions for impairment as necessary [7][8]. - The company uses the weighted average method for inventory cost determination and recognizes inventory at the lower of cost or net realizable value [22][23]. Financial Instruments - Financial assets are classified based on the business model for managing them and their cash flow characteristics, including those measured at amortized cost and those measured at fair value [9][10]. - The company recognizes expected credit losses for financial instruments based on their credit risk stages, with different measurement approaches for each stage [17][18]. Long-term Equity Investments - Long-term equity investments are accounted for using the cost method or the equity method, depending on the level of control or influence the company has over the investee [23][24]. - The company assesses whether there are indications of impairment for long-term equity investments and recognizes impairment losses when necessary [29][30]. Fixed Assets - Fixed assets are recognized at cost and depreciated using the straight-line method over their useful lives, with specific depreciation rates for different asset categories [30][31]. Intangible Assets - Intangible assets are recognized based on contractual or legal rights, with their useful lives determined accordingly. Research phase expenditures are expensed, while development phase expenditures may be capitalized if certain criteria are met [32][34].